688029 南微医学
已收盘 07-17 15:00:00
资讯
新帖
简况
股市必读：7月15日南微医学现3笔大宗交易 机构净卖出7439.67万元
证券之星 · 07-16 01:19
股市必读：7月15日南微医学现3笔大宗交易 机构净卖出7439.67万元
7月8日南微医学跌5.14%，中庚价值先锋股票基金重仓该股
证券之星 · 07-08
7月8日南微医学跌5.14%，中庚价值先锋股票基金重仓该股
每周股票复盘：南微医学（688029）境外收入增40.84%推动营收增长
证券之星 · 07-05
每周股票复盘：南微医学（688029）境外收入增40.84%推动营收增长
南微医学披露：受集采等因素冲击，多产品线内销收入毛利率双降
中金财经 · 07-01
南微医学披露：受集采等因素冲击，多产品线内销收入毛利率双降
股市必读：新发布《毕马威华振会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2025年年度报告的信息披露监管问询函的回复》
证券之星 · 07-01
股市必读：新发布《毕马威华振会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2025年年度报告的信息披露监管问询函的回复》
南微医学（688029）披露2025年年报问询函回复公告，6月29日股价上涨5.57%
证券之星 · 06-29
南微医学（688029）披露2025年年报问询函回复公告，6月29日股价上涨5.57%
南微医学涨5.57%，国金证券二个月前给出“买入”评级
证券之星 · 06-29
南微医学涨5.57%，国金证券二个月前给出“买入”评级
每周股票复盘：南微医学（688029）每股派现1.0元（含税）
证券之星 · 06-20
每周股票复盘：南微医学（688029）每股派现1.0元（含税）
南微医学（688029）披露2025年年度权益分派实施公告，6月16日股价下跌3.63%
证券之星 · 06-16
南微医学（688029）披露2025年年度权益分派实施公告，6月16日股价下跌3.63%
南微医学：推动AI技术在经营管理等场景融合应用
证券之星 · 06-11
南微医学：推动AI技术在经营管理等场景融合应用
每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案
证券之星 · 05-24
每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案
南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%
证券之星 · 05-21
南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%
南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%
证券之星 · 05-20
南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%
每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%
证券之星 · 05-17
每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%
南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%
证券之星 · 05-14
南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%
股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元
证券之星 · 05-06
股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元
东吴证券：给予南微医学买入评级
证券之星 · 05-04
东吴证券：给予南微医学买入评级
4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股
证券之星 · 04-28
4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股
国金证券：给予南微医学买入评级
证券之星 · 04-28
国金证券：给予南微医学买入评级
图解南微医学年报：第四季度单季净利润同比下降40.21%
证券之星 · 04-28
图解南微医学年报：第四季度单季净利润同比下降40.21%
加载更多
公司概况
公司名称：
南微医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜耗材类产品、肿瘤介入类产品、可视化类产品。公司被国家工业和信息化部认定为制造业单项冠军企业。
发行价格：
52.45
{"stockData":{"symbol":"688029","market":"SH","secType":"STK","nameCN":"南微医学","latestPrice":74.49,"timestamp":1784271600000,"preClose":78,"halted":0,"volume":2634115,"delay":0,"changeRate":-0.045,"floatShares":188000000,"shares":188000000,"eps":2.9591,"marketStatus":"已收盘","change":-3.51,"latestTime":"07-17 15:00:00","open":77.43,"high":78,"low":74.3,"amount":199000000,"amplitude":0.0474,"askPrice":74.49,"askSize":16,"bidPrice":74.48,"bidSize":10,"shortable":0,"etf":0,"ttmEps":2.9591,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":85.8,"lowLimit":70.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":187847422,"isCdr":false,"pbRate":3.3,"roa":"--","peRate":25.173195,"roe":"3.5%","epsLYR":3.05,"committee":0.05036,"marketValue":13993000000,"turnoverRate":0.014,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-07-20。","afterMarket":{"amount":0,"volume":0,"close":74.49,"buyVolume":0,"sellVolume":0,"time":1784273637746,"indexStatus":"已收盘 07-17 15:30:00","preClose":78},"floatMarketCap":13993000000},"requestUrl":"/m/hq/s/688029","defaultTab":"news","newsList":[{"id":"2651828460","title":"股市必读：7月15日南微医学现3笔大宗交易 机构净卖出7439.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651828460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651828460?lang=zh_cn&edition=full","pubTime":"2026-07-16 01:19","pubTimestamp":1784135949,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，南微医学报收于78.97元，上涨4.9%，换手率1.78%，成交量3.34万手，成交额2.61亿元。当日关注点交易信息汇总：7月15日南微医学主力资金净流出1543.12万元，机构通过大宗交易净卖出7439.67万元。大宗交易7月15日南微医学发生3笔大宗交易，机构净卖出7439.67万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600001653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969240","title":"7月8日南微医学跌5.14%，中庚价值先锋股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969240?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:28","pubTimestamp":1783499331,"startTime":"0","endTime":"0","summary":"证券之星消息，7月8日南微医学跌5.14%，收盘报73.01元，换手率1.16%，成交量2.19万手，成交额1.63亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为中庚基金的中庚价值先锋股票。中庚价值先锋股票目前规模为21.29亿元，最新净值0.9657，较上一交易日下跌1.33%，近一年下跌0.02%。中庚价值先锋股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800029172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694234","title":"每周股票复盘：南微医学（688029）境外收入增40.84%推动营收增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694234","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649694234?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:40","pubTimestamp":1783190422,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，南微医学报收于75.15元，较上周的69.84元上涨7.6%。本周，南微医学7月3日盘中最高价报75.9元。公司2025年实现营业收入31.62亿元，同比增长15.35%，其中境外销售收入19.15亿元，同比增长40.84%。公司对境内外经销商实施统一管控，境外子公司贡献营业收入14.64亿元，净利润1.50亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648851890","title":"南微医学披露：受集采等因素冲击，多产品线内销收入毛利率双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2648851890","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648851890?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:07","pubTimestamp":1782889621,"startTime":"0","endTime":"0","summary":"南微医学科技股份有限公司在近日发布的《关于2025年年度报告的信息披露监管问询函的回复公告》中，分产品列示了境内外销售收入和毛利率情况：报告期内，国内市场受集采政策及价格竞争影响，销售收入增长受阻，本期收入124750.14万元，同比下降9.72%，产品毛利率同比下降5.2个百分点。尽管集采带动销量增长，但以价换量效应短期内暂未抵消价格下行冲击，导致内镜耗材业务收入减少，产品毛利率下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260701/32296211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648614564","title":"股市必读：新发布《毕马威华振会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2025年年度报告的信息披露监管问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2648614564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648614564?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:05","pubTimestamp":1782849913,"startTime":"0","endTime":"0","summary":"公司公告汇总南微医学科技股份有限公司关于2025年年度报告的信息披露监管问询函的回复公告公司就上海证券交易所关于2025年年度报告的信息披露监管问询函作出回复，涉及主营业务收入与毛利率变动、境内外销售情况、境外资产管控、商誉减值测试等事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100005425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370864","title":"南微医学（688029）披露2025年年报问询函回复公告，6月29日股价上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370864","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647370864?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:18","pubTimestamp":1782742708,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，南微医学报收于73.73元，较前一交易日上涨5.57%，最新总市值为138.5亿元。该股当日开盘69.8元，最高75.8元，最低67.72元，成交额达2.25亿元，换手率为1.66%。近日，南微医学科技股份有限公司披露《毕马威华振会计师事务所关于南微医学科技股份有限公司2025年年度报告的信息披露监管问询函的回复》公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647242473","title":"南微医学涨5.57%，国金证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647242473","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647242473?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:35","pubTimestamp":1782722127,"startTime":"0","endTime":"0","summary":"今日南微医学涨5.57%，收盘报73.73元。2026年4月28日，国金证券研究员甘坛焕,何冠洲发布了对南微医学的研报《海外业务高增长，汇兑扰动短期业绩》，该研报对南微医学给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为7.02、8.63、10.51亿元，同比+23%、+23%、+22%，现价对应PE为20、16、14倍，维持“买入”评级。南微医学个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644066329","title":"每周股票复盘：南微医学（688029）每股派现1.0元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2644066329","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644066329?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:33","pubTimestamp":1781897590,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，南微医学报收于71.08元，较上周的73.71元下跌3.57%。本周，南微医学6月15日盘中最高价报74.89元。本周关注点公司公告汇总：南微医学2025年年度权益分派实施，每股现金红利1.0元（含税）。本次利润分配以实施权益分派股权登记日总股本扣减回购专用证券账户中股份数为基础，向全体股东每10股派发现金红利10.00元（含税），不送红股，不进行资本公积金转增股本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643675968","title":"南微医学（688029）披露2025年年度权益分派实施公告，6月16日股价下跌3.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643675968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643675968?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:50","pubTimestamp":1781607045,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，南微医学报收于70.7元，较前一交易日下跌3.63%，最新总市值为132.81亿元。该股当日开盘73.0元，最高73.0元，最低69.52元，成交额达1.43亿元，换手率为1.07%。近日，南微医学科技股份有限公司发布《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案为：每股派发现金红利1.0元（含税），股权登记日为2026年6月18日，除权（息）日与现金红利发放日均为2026年6月22日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642400857","title":"南微医学：推动AI技术在经营管理等场景融合应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2642400857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642400857?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:39","pubTimestamp":1781167187,"startTime":"0","endTime":"0","summary":"证券之星消息，南微医学(688029)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，当前AI人工智能发展迅猛，想了解下可以为公司带来哪些发展。南微医学回复：尊敬的投资者您好，公司一直关注人工智能发展，一方面持续推动深化AI技术在经营管理、流程优化、风险管控、供应链协同等场景的融合应用，以数字化手段提升运营效率；同时支持创新研究院组建AI研发团队，深化与临床内镜医师的医工协同，加快AI技术与微创诊疗器械的创新融合，以科技赋能产品升级与临床价值提升。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637337599","title":"每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2637337599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637337599?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:38","pubTimestamp":1779565091,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，南微医学报收于80.42元，较上周的82.28元下跌2.26%。本周关注点公司公告汇总：南微医学召开2025年度股东会，审议通过2025年度利润分配方案等八项议案。公司公告汇总：江苏新高的律师事务所确认南微医学2025年年度股东会会议程序合法有效。江苏新高的律师事务所出具法律意见书，见证南微医学科技股份有限公司2025年年度股东会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637810223","title":"南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637810223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637810223?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:50","pubTimestamp":1779357044,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，南微医学报收于80.78元，较前一交易日下跌0.09%，最新总市值为151.74亿元。近日，南微医学科技股份有限公司发布《关于2025年度暨2026年第一季度中英双语业绩说明会召开时间调整的公告》。公告显示，公司决定将原定于2026年5月27日下午14:30-15:30召开的业绩说明会，调整为15:00-16:00举行。会议将以直播及网络文字互动形式进行，平台为上证路演中心。会议结束后，投资者可通过上证路演中心查看会议回放。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636184868","title":"南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636184868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636184868?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:43","pubTimestamp":1779270193,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，南微医学报收于80.85元，较前一交易日下跌0.77%，最新总市值为151.87亿元。南微医学科技股份有限公司于2026年5月20日披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月19日在南京江北新区药谷大道199号召开2025年年度股东会，会议由董事会召集，董事长隆晓辉主持，采用现场与网络投票结合方式举行。出席会议股东及代理人共145人，代表有表决权股份总数110,472,084股，占公司总表决权股份的59.2007%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636064672","title":"每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636064672","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636064672?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:16","pubTimestamp":1778958972,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，南微医学报收于82.28元，较上周的83.0元下跌0.87%。本周，南微医学5月13日盘中最高价报86.3元。本周关注点公司公告汇总：南微医学2025年营业总收入31.84亿元，同比增长15.55%公司公告汇总：完成收购西班牙CME公司51%股权，启用泰国制造中心公司公告汇总：海外业务收入占比提升至60%公司公告汇总南微医学科技股份有限公司2025年年度股东会会议资料显示，2025年公司营业总收入31.84亿元，同比增长15.55%；归母净利润5.70亿元，同比增长3.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635713500","title":"南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635713500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635713500?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:53","pubTimestamp":1778752393,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，南微医学报收于82.66元，较前一交易日下跌3.68%，最新总市值为155.27亿元。该股当日开盘85.88元，最高86.28元，最低82.66元，成交额达1.36亿元，换手率为0.86%。公司于近日披露《南微医学科技股份有限公司2025年年度股东会会议资料》。公司营业总收入31.84亿元，同比增长15.55%；归母净利润5.70亿元，同比增长3.09%。全年召开7次董事会、4次股东大会，审议40项议案，决策程序合规高效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400033962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633356925","title":"股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633356925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633356925?lang=zh_cn&edition=full","pubTime":"2026-05-06 03:50","pubTimestamp":1778010619,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，南微医学报收于85.02元，上涨1.38%，换手率1.42%，成交量2.67万手，成交额2.26亿元。交易信息汇总资金流向4月30日主力资金净流入1094.85万元，占总成交额4.85%；游资资金净流入1733.67万元，占总成交额7.68%；散户资金净流出2828.52万元，占总成交额12.53%。大宗交易4月30日南微医学发生1笔折价10.88%的大宗交易，合计成交4796.24万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632931530","title":"东吴证券：给予南微医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2632931530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632931530?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:05","pubTimestamp":1777885526,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对南微医学进行研究并发布了研究报告《2025年报&2026一季报点评：国际市场表现亮眼，创新产品快速增长》，给予南微医学买入评级。26Q1海外收入占总收入比例提升至61.26%。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为97.8。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050400003632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630750403","title":"4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630750403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630750403?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:25","pubTimestamp":1777364705,"startTime":"0","endTime":"0","summary":"证券之星消息，4月28日南微医学涨10.70%，收盘报83.88元，换手率3.64%，成交量6.84万手，成交额5.63亿元。重仓南微医学的前十大公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为97.65。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为中庚基金的中庚价值先锋股票。该公募基金现任基金经理为陈涛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800048864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630448753","title":"国金证券：给予南微医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630448753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630448753?lang=zh_cn&edition=full","pubTime":"2026-04-28 08:35","pubTimestamp":1777336558,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对南微医学进行研究并发布了研究报告《海外业务高增长，汇兑扰动短期业绩》，给予南微医学买入评级。其中，一次性内镜步入良性发展轨道，海外销售表现亮眼，美洲市场实现翻倍增长，欧洲区域同比增幅超70%；国内终端销量稳步攀升，业务发展迈入良性循环。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为97.65。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800027564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630331980","title":"图解南微医学年报：第四季度单季净利润同比下降40.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630331980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630331980?lang=zh_cn&edition=full","pubTime":"2026-04-28 00:59","pubTimestamp":1777309148,"startTime":"0","endTime":"0","summary":"证券之星消息，南微医学2025年年报显示，当年度公司主营收入31.84亿元，同比上升15.55%；归母净利润5.7亿元，同比上升3.09%；扣非净利润5.52亿元，同比上升1.44%；其中2025年第四季度，公司单季度主营收入8.03亿元，同比上升8.11%；单季度归母净利润6106.34万元，同比下降40.21%；单季度扣非净利润4408.77万元，同比下降55.11%；负债率20.53%，投资收益1694.2万元，财务费用-6603.76万元，毛利率64.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784353479863,"stockEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0799},{"period":"3month","weight":0.0273},{"period":"6month","weight":-0.1338},{"period":"1year","weight":-0.0042},{"period":"ytd","weight":-0.0737}],"compareEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.0709},{"period":"6month","weight":-0.0823},{"period":"1year","weight":0.0703},{"period":"ytd","weight":-0.0516}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南微医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"11634人(较上一季度减少0.74%)","perCapita":"16146股","listingDate":"2019-07-22","address":"江苏省南京市浦口区高新开发区高科三路10号","registeredCapital":"18784万元","survey":" 南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜耗材类产品、肿瘤介入类产品、可视化类产品。公司被国家工业和信息化部认定为制造业单项冠军企业。","listedPrice":52.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南微医学,688029,南微医学股票,南微医学股票老虎,南微医学股票老虎国际,南微医学行情,南微医学股票行情,南微医学股价,南微医学股市,南微医学股票价格,南微医学股票交易,南微医学股票购买,南微医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}